The HTA Writer is responsible for providing clinical EUHTA document support to the JCA core team, ensuring successful preparation of high-quality submission-ready documents and effective implementation of the clinical writing process.

Provides HTA writing expertise for multiple compounds and/or projects, expertise in HTA, oncology is a plus within a therapeutic area.

Interfaces with JCA core and extended teams (e.g., HTA Strategy, Access, DSS HTA Stats, VAC, HEOR Strategy, Medical Affairs, Regulatory, Safety) to ensure accurate and timely completion/delivery of information and review of EUHTA submissions.

Responsibilities:

• Able to write less complex document types (unmet need, disease burden sections), with little supervision.
• Requires close supervision/mentoring on more complex document type and relies on review of subject matter experts and more senior writers for verification.
• Effectively communicates JCA document deliverables needed, writing process, and timelines to team members. Holds team members accountable to agreed-upon project dates.
• Identifies and proposes solutions to resolve issues and questions arising during the writing process, including elevation as appropriate.
• Understands/complies with appropriate conventions, proper grammar usage, and correct format requirements per EU HTA regulations and guidance materials.
• Arranges and conducts review meetings with the team.
• Acts as interface to resolve issues and questions arising during the writing process. Works with manager throughout the document audit process and works with JCA Core team and manager to draft responses as necessary.
• Produces and maintains focusing on quality and compliance and ensures delivery within project timelines.
• Familiarity with HTA dossier regulations, requirements and guidance associated with EU HTA regulations.